Antidiabetes Xii.

Institut klinicke a experimentalni mediciny Czech Republic has Released a tender for Antidiabetes Xii. in Pharmaceuticals. The tender was released on Aug 12, 2024.

Country - Czech Republic

Summary - Antidiabetes Xii.

Deadline - login to view

MT reference number - 90696381

Product classification - Medicinal products used in diabetes

Organization Details:

  Address - Czech Republic

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90696381

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The subject of the public contract is the regular supply of medicinal products containing the active substances empagliflozin, linagliptin and the empagliflozin/metformin combination (ATC A10BK03, A10BH05, A10BD20) for the treatment of p atients in approved indications according to the SPC valid on the date of submission of the offer.notice_title: Antidiabetes Xii.contract_duration: 48 MONTHnotice_contract_type: Goodslocal_description: Předmětem veřejné zakázky jsou pravidelné dodávky léčivých přípravků obsahující účinné látky empagliflozin, linagliptin a kombinaci empagliflozin/metformin (ATC A10BK03, A10BH05, A10BD20) pro léčbu pacientů ve schválených in

Mt Ref Id - 90696381

Deadline - Sep 10, 2024

Share

Similar Tenders :